Latest Articles

Publication Date
All News Scientific
Recurrent Abdominal Pain Caused by a Parasitic Leiomyoma Containing Endometrial Cells Following Laparoscopic Hysterectomy - Cureus

Recurrent Abdominal Pain Caused by a Parasitic Leiomyoma Containing Endometrial Cells Following Laparoscopic Hysterectomy Cureus

Published: May 19, 2025, 11:07 a.m.
Read Full Article
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer - Healio

VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer Healio

Published: May 14, 2025, 8:04 p.m.
Read Full Article
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Real-World Use of ICI in Advanced or Recurrent Endometrial Cancer - OncLive

Real-World Use of ICI in Advanced or Recurrent Endometrial Cancer OncLive

Published: April 14, 2025, 2:41 p.m.
Read Full Article
Comprehensive individualised interventions may improve clinical outcomes for patients with Recurrent Implantation Failure: Study - Medical Dialogues

Comprehensive individualised interventions may improve clinical outcomes for patients with Recurrent Implantation Failure: Study Medical Dialogues

Published: April 10, 2025, 2:45 p.m.
Read Full Article
Expert Opinion: Place in Therapy of Probiotics in Infertility and Recurrent Implantation Failure - Cureus

Expert Opinion: Place in Therapy of Probiotics in Infertility and Recurrent Implantation Failure Cureus

Published: March 24, 2025, 11:52 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!